• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Number of highest risk domestic inspections in the quarter resulting in a category of classifications called OTHER

Dictionary: The number of inspections where one of the following four outcomes occurred. 1. Referred to State for Follow-Up: the findings of the inspection were such that there is no federal jurisdiction over the apparent violation in question or it is determined that State action is the most efficient method of obtaining the establishment’s compliance with Federal laws, regulations or administrative requirements. 2. Referred to Center: the Establishment Inspection Report has been referred to the appropriate Center for a final inspection district decision. 3. Not Yet Completed by Investigator: the inspection has been completed but the investigator has not yet reported [into the database] what district decision will be recommended. 4. Not Yet Endorsed by Investigations: the investigator’s recommendation regarding the district decision has not yet been endorsed (reviewed and approved) by the investigator’s supervisor.

Fiscal Year - 2010

Skip graphic and jump to text data

TimeTargetNumber Classified as Other
Oct 2009N/A4
Nov 2009N/A2
Dec 2009N/A7
Jan 2010N/A9
Feb 2010N/A3
Mar 2010N/A13
Apr 2010N/A5
May 2010N/A8
Jun 2010N/A3
Jul 2010N/A5
Aug 2010N/A9
Sep 2010N/A16

FY 2010 Overall: 84

Percent of highest risk domestic inspections in the quarter resulting in a classification of Other

Fiscal Year - 2010
Skip graphic and jump to text data.

TimeTargetPercent Classified as Other
Oct 2009N/A1
Nov 2009N/A0
Dec 2009N/A1
Jan 2010N/A1
Feb 2010N/A0
Mar 2010N/A1
Apr 2010N/A1
May 2010N/A1
Jun 2010N/A0
Jul 2010N/A1
Aug 2010N/A1
Sep 2010N/A2


Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.